Mostrar el registro sencillo del ítem

dc.contributor.authorDubey, Rashmi
dc.contributor.authorSingh, Praveen
dc.contributor.authorK. Singh, Ajeet
dc.contributor.authorK. Yadav, Manoj
dc.contributor.authorSwati, D.
dc.contributor.authorVinayak, Manjula
dc.contributor.authorRavi Kumar, K.
dc.contributor.authorSridhar, B.
dc.contributor.authorK. Tewari, Ashish
dc.contributor.authorPuerta Vizcaino, María del Carmen
dc.contributor.authorValerga Jiménez, Pedro Sixto
dc.contributor.otherCiencia de los Materiales e Ingeniería Metalúrgica y Química Inorgánicaen_US
dc.date.accessioned2018-05-07T06:58:59Z
dc.date.available2018-05-07T06:58:59Z
dc.date.issued2014-02
dc.identifier.urihttp://hdl.handle.net/10498/20451
dc.description.abstractWeak noncovalent interactions are the basic forces in crystal engineering. Polymorphism in flexible molecules is very common, leading to the development of the crystals of same organic compounds with different medicinal and material properties. Crystallization of 2,2′- {[1,2-phenylenebis(methylene)]bis(sulfanediyl)}bis(4,6-dimethylnicotinonitrile) by evaporation at room temperature from ethyl acetate and hexane and from methanol and ethyl acetate gave stable polymorphs 4a and 4b, respectively, while in acetic acid, it gave metastable polymorph 4c. The polymorphic behavior of the compound has been visualized through singlecrystal X-ray and Hirshfeld analysis. These polymorphs are tested for anti-inflammatory activity via the complete Freund’s adjuvant-induced rat paw model, and compounds have exhibited moderate activities. Studies of docking in the catalytic site of cyclooxygenase-2 were used to identify potential anti-inflammatory lead compounds. These results suggest that the supramolecular aggregate structure, which is formed in solution, influences the solid state structure and the biological activity obtained upon crystallization.en_US
dc.formatapplication/pdfen_US
dc.language.isoengen_US
dc.publisherACS Publicationsen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceCrystal Growth & Design 2014, 14, 1347−1356en_US
dc.titlePolymorphic Signature of the Anti-inflammatory Activity of 2,2′- {[1,2-Phenylenebis(methylene)]bis(sulfanediyl)}bis(4,6- dimethylnicotinonitrile)en_US
dc.typejournal articleen_US
dc.rights.accessRightsclosed access
dc.identifier.doi10.1021/cg401842y


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Internacional